Skip to content

Immediate Implant Placement Using Tunneling Technique with Connective Tissue Graft versus Coated and Non-Coated DuraGen Matrix with Concentrated Growth Factors

Immediate Implant Placement Using Tunneling Technique with Connective Tissue Graft versus Coated and Non-Coated DuraGen Matrix with Concentrated Growth Factors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202407826889857
Enrollment
24
Registered
2024-07-22
Start date
2022-02-28
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Health

Interventions

Duragen collagen matrix
Coated Duragen collagen matrix

Sponsors

Oral Medicine Periodontology Oral Diagnosis and Radiology Department Faculty of Dentistry Tanta University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients in good health with absence of relevant medical condition that contraindicate implant placement e.g. uncontrolled diabetes mellitus or blood coagulation disorder. - Optimal compliance as evidenced by no missed treatment. appointments and a positive attitude toward oral hygiene. - Full mouth plaque score and bleeding on probing 3 mm at mid-buccal aspect of failing tooth. - Soft tissue level is at the same level of the contralateral tooth. - Presence of adjacent and opposing dentition. - Presence of enough mesiodistal and interocclusal space for non-occluding provisional restoration.

Exclusion criteria

Exclusion criteria: - History of cancer or head and neck radiation. - Extraction socket type II or type III. - Patients with parafunctional occlusal habits as bruxism and clenching that produce overload on the implant. - History of periodontal surgeries or presence of acute infection in the area planned for surgery. - Pregnant females. - Smoking > 10 cigarettes per day.

Design outcomes

Primary

MeasureTime frame
Facial Bone Thickness ; Facial Soft Tissue Thickness ;Keratinized Mucosal Width

Secondary

MeasureTime frame
Pink Ethestic Score

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026